We fund a Surgical Specialty Lead in advanced bowel cancer
We’re delighted to announce the Royal College of Surgeons of England (RCS) are creating a Surgical Specialty Lead in colorectal liver metastases. This exciting new post is funded by Bowel Cancer UK, working in partnership with the Association of Upper Gastrointestinal Surgeons (AUGIS).
Bowel cancer is the second biggest cancer killer in the UK. Around 10,000 people every year are diagnosed with advanced stage 4 bowel cancer (known as metastases). Stage 4 is when the cancer has spread from the bowel to other organs, most often the liver or lungs. Survival rates for advanced bowel cancer are poor, with fewer than one in ten diagnosed at the latest stage of bowel cancer surviving for five years.
Patients with advanced disease are limited in their treatment options and often struggle to access liver and lung specialists as part of their ongoing care. Over the three year appointment, the Surgical Specialty Lead will strive to address some of these issues in treatments for liver metastases by developing new clinical trials and driving innovative research in this area. The new lead will be a liver surgeon with a particular interest in advanced disease.
Deborah Alsina MBE, Chief Executive of Bowel Cancer UK, said: “We’re delighted to be working with AUGIS and RCS to fund this new post which will be instrumental in encouraging more surgical research into advanced bowel cancer, which is unfortunately woefully low.
"This forms a key part of the charity’s five year research strategy and our Get Personal campaign which aims to improve outcomes for people with advanced disease. We hope that this new post will be able to develop solutions that directly lead to a reduction in the number of lives lost from the disease and drive improvements in quality of life where cure is not possible.”
Professor Dion Morton, RCS Director of Clinical Research, said: “This exciting new appointment will result in more research focusing on developing better, and potentially curative, treatments for advanced bowel cancers."
- Apply for the position of RCS Surgical Specialty Lead
- Find out more about our research priorities and Get Personal campaign
- Read our exclusive blogs where we share latest research updates.
- Donate and help fund our vital research and